Quick Answer
MEDICINOVA INC reported Stockholders Equity of $41.59 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -20.8% in Stockholders Equity from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $22.95 million | Q3 2013: $21.45 million | Q1 2014: $26.65 million | Q2 2014: $24.80 million | Q3 2014: $22.98 million | Q1 2015: $20.95 million | Q2 2015: $19.95 million | Q3 2015: $34.63 million | Q1 2016: $39.14 million | Q2 2016: $37.37 million | Q3 2016: $35.75 million | Q1 2017: $32.75 million | Q2 2017: $33.39 million | Q3 2017: $34.72 million | Q1 2018: $75.57 million | Q2 2018: $75.59 million | Q3 2018: $73.55 million | Q1 2019: $75.04 million | Q2 2019: $73.18 million | Q3 2019: $74.35 million | Q1 2020: $73.20 million | Q2 2020: $71.09 million | Q3 2020: $73.55 million | Q1 2021: $92.37 million | Q2 2021: $89.23 million | Q3 2021: $86.48 million | Q1 2022: $80.36 million | Q2 2022: $76.61 million | Q3 2022: $73.11 million | Q1 2023: $67.73 million | Q2 2023: $65.18 million | Q3 2023: $64.67 million | Q1 2024: $59.83 million | Q2 2024: $57.41 million | Q3 2024: $55.07 million | Q1 2025: $49.93 million | Q2 2025: $46.86 million | Q3 2025: $43.96 million.
- Over the full 18 years of available data (2008 to 2025), MEDICINOVA INC's Stockholders Equity has declined by 13.4%.
- Historical annual values: Fiscal year 2025: $41.59 million | Fiscal year 2024: $52.50 million | Fiscal year 2023: $62.38 million | Fiscal year 2022: $70.24 million | Fiscal year 2021: $83.68 million | Fiscal year 2020: $71.33 million | Fiscal year 2019: $74.89 million | Fiscal year 2018: $73.11 million | Fiscal year 2017: $38.64 million | Fiscal year 2016: $34.53 million | Fiscal year 2015: $32.75 million | Fiscal year 2014: $22.01 million | Fiscal year 2013: $25.43 million | Fiscal year 2012: $14.88 million | Fiscal year 2011: $23.50 million | Fiscal year 2010: $24.70 million | Fiscal year 2009: $40.01 million | Fiscal year 2008: $48.04 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: